A fully synthetic vaccine consisting of a tumor-associated glycopeptide antigen and a T-cell epitope for the induction of a highly specific humoral immune response.
Dziadek
Sebastian
S
Institut für Organische Chemie, Johannes Gutenberg-Universität Mainz, Mainz, Germany.
Hobel
Alexandra
A
Schmitt
Edgar
E
Kunz
Horst
H
D000917:Antibody Formation / Q000276:immunology*; D000918:Antibody Specificity; D000951:Antigens, Neoplasm / Q000737:chemistry* / Q000276:immunology; D019496:Cancer Vaccines / Q000138:chemical synthesis / Q000737:chemistry* / Q000276:immunology; D002236:Carbohydrate Conformation; D002240:Carbohydrate Sequence; D018984:Epitopes, T-Lymphocyte / Q000737:chemistry / Q000276:immunology*; D006020:Glycopeptides / Q000737:chemistry* / Q000276:immunology; D018448:Models, Immunological; D008969:Molecular Sequence Data; D018396:Mucin-1 / Q000737:chemistry / Q000276:immunology; D013237:Stereoisomerism; D014614:Vaccines, Synthetic / Q000737:chemistry* / Q000276:immunology
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D018984:Epitopes, T-Lymphocyte; D006020:Glycopeptides; D018396:Mucin-1; D014614:Vaccines, Synthetic